Tag: Pfizer Inc

  • Hot Health Stocks: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Gilead Sciences, Inc. (NASDAQ:GILD), Merck & Co (NYSE:MRK), Pfizer Inc. (NYSE:PFE)

    Ariad Pharmaceuticals (NASDAQ:ARIA) was upgraded by research analysts at BMO Capital Markets to an “outperform” rating in a report released on Friday, Analyst Ratings.Net reports. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $7.02 in last trading session, and closed at $7.00, trading in the range of $6.87 – $7.32. The stock showed a negative weekly performance of -12.94%.

    Gilead Sciences, Inc. (NASDAQ:GILD) announced its results of operations for the fourth quarter and full year 2013. Total revenues for the fourth quarter of 2013 increased 21 percent to $3.12 billion, from $2.59 billion for the fourth quarter of 2012. Net income for the fourth quarter of 2013 was $791.4 million, or $0.47 per diluted share compared to $762.5 million, or $0.47 per diluted share for the fourth quarter of 2012. Non-GAAP net income for the fourth quarter of 2013, which excludes acquisition-related, restructuring and stock-based compensation expenses, was $929.8 million, or $0.55 per diluted share compared to $823.4 million, or $0.50 per diluted share for the fourth quarter of 2012. Gilead Sciences, Inc. (NASDAQ:GILD) shares closed at $82.02 on last trade day, by gaining 82.02. Stock 52 week range is $39.48 – $84.40. Company’s market capitalization is $125.77 billion.

    Merck & Co (NYSE:MRK) is set to issue its quarterly earnings data on Wednesday, February 5th. Individual interested in participating in the company’s earnings conference call can do so using this link. Merck & Co., Inc. (NYSE:MRK) stock increased 2.75% and finished the last session at $53.51. The EPS of the stock remained 1.51. Company’s market capitalization is $156.60 billion.

    Jeffries upgraded Pfizer Inc. (NYSE:PFE) to “buy” from “hold” and set a target price of $38. The firm believes that Palbociclib is under-appreciated and also notes that restructuring should increase operational efficiency and improve the tax structure. Pfizer Inc. (NYSE:PFE) stock opened at $82.02 in last trading session and closed at $31.64. The 52 week range of the stock is $26.79 – $32.50 and the day range was $30.60 – $32.00.